Appeals Court: Pfizer Liable for Asbestos Claims against Quigley Corp.Legislation & Litigation
Written by Tim Povtak
Asbestos.com is the nation’s most trusted mesothelioma resource
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
About The Mesothelioma Center at Asbestos.com
- Assisting mesothelioma patients and their loved ones since 2006.
- Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
- A+ rating from the Better Business Bureau.
- 5-star reviewed mesothelioma and support organization.
My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.LashawnMesothelioma patient’s daughter
How to Cite Asbestos.com’s Article
Povtak, T. (2020, October 16). Appeals Court: Pfizer Liable for Asbestos Claims against Quigley Corp.. Asbestos.com. Retrieved December 1, 2023, from https://www.asbestos.com/news/2012/04/12/pfizer-liable-for-quigley-asbestos/
Povtak, Tim. "Appeals Court: Pfizer Liable for Asbestos Claims against Quigley Corp.." Asbestos.com, 16 Oct 2020, https://www.asbestos.com/news/2012/04/12/pfizer-liable-for-quigley-asbestos/.
Povtak, Tim. "Appeals Court: Pfizer Liable for Asbestos Claims against Quigley Corp.." Asbestos.com. Last modified October 16, 2020. https://www.asbestos.com/news/2012/04/12/pfizer-liable-for-quigley-asbestos/.
Pharmaceutical giant Pfizer is liable for the asbestos insulating products made decades ago by Quigley Corporation, one of its now-bankrupt subsidiaries, based on a New York federal appellate court ruling his week.
Although Pfizer never made any Quigley products, its logo appeared on the advertising and packages that were being sold, a fact that convinced the court to uphold a previous ruling at the district level.
Quigley made several products containing asbestos that were used in the steel industry from the 1940s to the 1970s. One of them was an insulator known as “Insulag,” that was used in high-heat environments.
Quigley Corporation was acquired by Pfizer in 1968 and stopped most of its operations by 1992, filing for bankruptcy in 2004.
More than 160,000 plaintiffs filed asbestos-related claims against Quigley before the bankruptcy protection, and an estimated $430 million was paid out to settle the majority of the claims.
A U.S. Bankruptcy judge originally ruled that the remaining asbestos claims would be barred, but in May of 2011 that ruling was reversed. Although Pfizer appealed that ruling, the federal court this week opened the door even wider for future claims against the drug maker regarding Quigley.
Some of the claims date back to the ’70s. The lengthy latency period of asbestos diseases (10 to 50 years) between exposure to asbestos and the symptoms of mesothelioma have kept those claims relevant.
The case was another blow to the big businesses that have tried to skirt the responsibility for the death and destruction caused by asbestos, which can lead to a number of serious, long-term health issues, including mesothelioma cancer.
Also this week, Minnesota governor Mark Dayton vetoed proposed legislation that would have limited liability claims against companies that merge with, or buy, other companies with past asbestos issues.
The legislation was designed to protect Crown Holdings, the multi-billion dollar packaging company, from future claims related to its 1963 purchase of another company.
Pfizer, meanwhile, reported a $701 million third-quarter charge in 2011 for asbestos litigation related to Quigley, according to Bloomberg.Net.